- Cellectar Biosciences (NASDAQ:CLRB) has priced its public offering for gross proceeds of $20M.
- The offering is priced at $1.15/share of common stock and one-half of a Series H Warrant.
- Each five-year whole Series H Warrant is exercisable to purchase one common share at an exercise price of $1.21/share.
- Closing date is June 5.
- Shares are down 23% premarket.
Cellectar Bio plunges 23% after pricing $20M public offering
Recommended For You
About CLRB Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CLRB | - | - |
Cellectar Biosciences, Inc. |